XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue        
Sales   $ 15,937 $ 1,177 $ 48,021
Grant revenue   34,964 77,482 127,009
Total revenue   50,901 78,659 175,030
Cost of sales   4,049 690 44,792
Gross profit   46,852 77,969 130,238
Operating expenses        
Research and development $ 428,771 90,658 1,129,286 133,074
General and administrative 489,729 360,944 1,700,340 1,173,565
Total operating expenses 918,500 451,602 2,829,626 1,306,639
Operating loss (918,500) (404,750) (2,751,657) (1,176,401)
Other (income) and expenses        
Unrealized loss (gain) on marketable securities 242 (54,266)
Realized loss on marketable securities 106,324
Interest and other income (9,981) (93) (18,457) (190,193)
Change in fair value of convertible notes 193,776 195,962
Loss on extinguishment of convertible notes 934,257
Interest expense 17,188 41,066 73,560 189,993
Net loss $ (925,949) $ (639,499) $ (2,858,818) $ (2,306,420)
Net loss per share - basic and diluted (in Dollars per share) $ (0.08) $ (0.09) $ (0.24) $ (0.41)
Weighted average common shares - basic and diluted (in Shares) 11,886,379 7,171,232 11,886,379 5,642,100